Monthly Archives: March 2022

• 

European Association of Urology kidney cancer guidelines updated

By Sharon Deveson Kell|2022-03-31T09:33:57+00:0031 Mar 2022|Drug treatments|

The European Association of Urology have recently updated their clinical [...]

Read More

Comments Off on European Association of Urology kidney cancer guidelines updated

• 

Changes to COVID-19 testing in England from 1 April

By Sharon Deveson Kell|2022-04-01T06:59:59+00:0031 Mar 2022|Uncategorized|

From tomorrow, there will be changes to the availability of [...]

Read More

Comments Off on Changes to COVID-19 testing in England from 1 April

• 

NHS 10-year Cancer Plan for England

By Sharon Deveson Kell|2022-03-30T14:11:19+00:0030 Mar 2022|Cancer news, Patient advocacy|

The government have put out a call for evidence for [...]

Read More

Comments Off on NHS 10-year Cancer Plan for England

• 

Health and Care Bill – Workforce Amendment

By Sharon Deveson Kell|2022-03-30T07:50:20+00:0030 Mar 2022|Cancer news, Patient advocacy|

Today the House of Commons will be considering the changes [...]

Read More

Comments Off on Health and Care Bill – Workforce Amendment

• 

COVID-19 lateral flow tests

By Sharon Deveson Kell|2022-03-29T08:05:44+00:0029 Mar 2022|Cancer news|

At the moment, you can still order free lateral flow [...]

Read More

Comments Off on COVID-19 lateral flow tests

• 

NHS workforce shortage has serious effect on services

By Sharon Deveson Kell|2022-03-29T12:42:53+00:0029 Mar 2022|Cancer news, Patient advocacy|

Today NHS Providers published findings from a recent survey of [...]

Read More

Comments Off on NHS workforce shortage has serious effect on services

• 

Yorkshire Kidney Screening Trial

By Sharon Deveson Kell|2022-03-28T10:16:42+00:0028 Mar 2022|Cancer news|

Kidney cancer is the 8th most common cancer in Yorkshire. [...]

Read More

Comments Off on Yorkshire Kidney Screening Trial

• 

Nivolumab plus ipilimumab and live bacteria supplements in advanced kidney cancer

By Sharon Deveson Kell|2022-03-25T09:17:25+00:0025 Mar 2022|Drug treatments|

Researchers are interested in the bacteria in our gut (the [...]

Read More

Comments Off on Nivolumab plus ipilimumab and live bacteria supplements in advanced kidney cancer

• 

Cancer52 All Member Meeting

By Sharon Deveson Kell|2022-03-18T14:21:33+00:0018 Mar 2022|Cancer news, Patient advocacy|

Cancer52 is an alliance of over 100 organisations, united in [...]

Read More

Comments Off on Cancer52 All Member Meeting

• 

ABPI Patient Organisation Forum

By Sharon Deveson Kell|2022-03-18T09:09:06+00:0018 Mar 2022|Cancer news, Patient advocacy|

This was the first Association of British Pharmaceutical Industry (ABPI) [...]

Read More

Comments Off on ABPI Patient Organisation Forum